Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Bone morphogenetic proteins (e.g., BMP9\; MIM 605120) are members of the transforming growth factor-beta (see TGFB1\; MIM 190180) superfamily and regulate tissue differentiation and maintenance. Additionally we are shipping GDF15 Kits (68) and GDF15 Proteins (41) and many more products for this protein.
Showing 10 out of 319 products:
Chimpanzee Polyclonal GDF15 Primary Antibody for EIA, WB - ABIN453968
Baek, Eling: Changes in gene expression contribute to cancer prevention by COX inhibitors. in Progress in lipid research 2006
Show all 2 references for ABIN453968
Chimpanzee Polyclonal GDF15 Primary Antibody for EIA, WB - ABIN453964
Lindmark, Zheng, Wiklund, Bensen, Bälter, Chang, Hedelin, Clark, Stattin, Meyers, Adami, Isaacs, Grönberg, Xu: H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. in Journal of the National Cancer Institute 2004
Show all 2 references for ABIN453964
Human Polyclonal GDF15 Primary Antibody for ELISA, WB - ABIN185465
Wollmann, Goodman, Bhat-Nakshatri, Kishimoto, Goulet, Mehrotra, Morimiya, Badve, Nakshatri: The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. in Carcinogenesis 2005
association of elevated GDF-15 levels with increased risk of mortality in patients with heart failure [meta-analysis]
MIC-1/GDF15 may provide a link between childhood obesity and cardio metabolic complications that will occur in time course.
GDF-15, sST2 (show SSTR2 Antibodies), and hs-TnI (show TNNI2 Antibodies) are associated with incident cardiovascular disease and heart failure
GDF15 was statistically significantly higher in patients with nasal polyps than in controls.
GDF-15 is a valuable predictor of cardiovascular death in a population of coronary artery disease patients after PCI (show SERPINA5 Antibodies)
High glucose and insulin (show INS Antibodies) peaks up-regulate GDF15 transcription and release.
Data suggest that increased GDF-15 levels were positively associated with coronary artery disease.
High expression of GDF15 is associated with ovarian cancer.
Role of GDF15 in Type 2 diabetes mellitus. [review]
High MIC-1 (show C18orf8 Antibodies) expression is associated with weight loss and poor response to chemotherapy in esophageal squamous cell carcinoma.
The results of this study indicated the importance of Gdf-15 in promoting survival of DAergic neurons and regulating the inflammatory response post 6-OHDA lesion.
endogenous Growth/differentiation factor-15 is beneficial for axon regeneration following sciatic nerve crush
repeated cisterna magna administration of human umbilical cord blood-derived mesenchymal stem cells enhanced endogenous adult hippocampal neurogenesis and synaptic activity through a paracrine factor of GDF-15
Levels of GDF-15 mRNA increased 2 h after induction of ventilator-induced lung injury in WT lungs. Non-hematopoietic cells are the main source of GDF-15. GDF-15 is required for platelet-leukocyte interactions during ventilator-induced lung injury.
hNAG-1 appears to be a novel therapeutic target in preventing and treating obesity and insulin (show INS Antibodies) resistance.
Counterbalance between MIC-1 and ATF3 (show ATF3 Antibodies) is critical for deciding the fate of enterocytes under the food chemical stress.
Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
Growth/differentiation factor 15 promotes EGFR (show EGFR Antibodies) signalling, and regulates proliferation and migration in the hippocampus of neonatal and young adult mice.
GDF-15 is therefore prominently upregulated in the retina after optic nerve crush but does not directly interfere with the magnitude and temporal progression of retinal ganglion cell death.
GDF15 protects the renal interstitium and tubular compartment in experimental type 1 and 2 diabetes without affecting glomerular damage
Bone morphogenetic proteins (e.g., BMP9\; MIM 605120) are members of the transforming growth factor-beta (see TGFB1\; MIM 190180) superfamily and regulate tissue differentiation and maintenance. They are synthesized as precursor molecules that are processed at a dibasic cleavage site to release C-terminal domains containing a characteristic motif of 7 conserved cysteines in the mature protein.
growth differentiation factor 15
, NSAID (nonsteroidal anti-inflammatory drug)-activated protein 1
, NSAID-activated gene 1 protein
, NSAID-regulated gene 1 protein
, growth/differentiation factor 15
, macrophage inhibitory cytokine 1
, placental TGF-beta
, placental bone morphogenetic protein
, prostate differentiation factor
, macrophage inhibiting cytokine-1